An interventional study of Moisturizing while in shower/bath and Moisturizing after towel drying in Atopic Dermatitis (AD) and Atopic Dermatitis (Eczema), sponsored by University of British Columbia. Not yet recruiting at 1 site in Canada. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-12-08.
Sponsored by University of British Columbia · Not applicable, Interventional, and Prevention
Skin moisturization is important for patients with atopic dermatitis, commonly known as eczema. Moisturizing right after bathing is widely accepted as the best method to keep skin hydrated. However, there is conflicting research on the timing of moisturizing. The goal of this clinical study is to evaluate the preference of moisturizing while showering/bathing compared to after towel drying in adolescents aged 12-18 with eczema. The main question it aims to answer are:
Researchers will compare applying moisturizer while in the shower/bath to after towel drying and to which technique is preferred among participants and if there are different effects on eczema and skin hydration.
Participants will:
1,419 studies on the registry are indexed under Dermatitis, Atopic; 258 are open to participants now.
This study's planned enrollment of 30 is below the median of 83 across 1,125 interventional studies indexed under Dermatitis, Atopic.
Browse Dermatitis, Atopic studies →University of British Columbia is the lead sponsor of 1,309 studies on the registry; 253 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Behavioral: Moisturizing while in shower/bath
Behavioral: Moisturizing after towel drying
Applying moisturizer in the shower/bath.
Applying moisturizer out of the shower/bath after towel drying.
Proportion of Participants Preferring Each Moisturization Technique
Participant reported preference of moisturization technique
Time frame: Through study completion, an average of 2 months.
Skin Hydration Level
Skin electrical capacitance measured using Corneometer® CM825 as an indicator of skin hydration.
Time frame: Through study completion, an average of 2 months.
Eczema Severity Score
Eczema severity will be assessed by clinicians using the Validated Investigator Global Assessment Scale for Atopic Dermatitis (vIGA-AD™). Scores range from 1 to 4, with higher scores indicating more severe eczema/atopic dermatitis (worse outcome).
Time frame: Through study completion, an average of 2 months.
Itch Intensity
Itch intensity will be assessed using a patient-reported Numeric Rating Scale (NRS) ranging from 1 to 10, where higher scores indicate greater itch severity (worse outcome). Participants will report both average itch and worst itch experienced within the past 24 hours.
Time frame: Through study completion, an average of 2 months.
Plan to share: No — Individual participant data will not be shared, but aggregated data from all participants will be shared.
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of British Columbia